Is progesterone the same as a progestin? It sounds like it should be. It is absolutely not. And that distinction matters more than most women — and many providers — realize.

This is the conversation Dr. Carolyn Moyers has multiple times a day in clinic — especially with women in perimenopause who are trying to understand their options, figure out why a previous hormone regimen made them feel worse, or advocate for a prescription that actually fits their biology. It is also one of the most consequential mix-ups in all of menopause medicine, and it is long overdue for a dedicated episode.

Bioidentical progesterone and synthetic progestins are not interchangeable. They have different molecular structures, different receptor profiles, and meaningfully different effects on your breast tissue, your cardiovascular system, your sleep, and your brain. The WHI study — the one that scared a generation of women off hormone therapy — tested a synthetic progestin, not bioidentical progesterone. And the breast cancer finding it reported was not even statistically significant. That context has been almost entirely missing from the public conversation. Until now.

In this episode:

• What bioidentical progesterone actually is — and how it differs from synthetic progestins at the molecular level

• The WHI study: what it actually tested, and why its results have been misapplied for 20+ years

• Breast cancer risk: the ESTHER study and what the evidence actually shows

• Cardiovascular differences between progesterone and MPA (Provera)

• Why progesterone is a neuroactive steroid — and what that means for your sleep, anxiety, and mood

• Uterine protection: what it is, why it matters, and whether bioidentical progesterone is sufficient

• What to do if you don’t have a uterus — and whether you still need progesterone

• Perimenopause: why the progestogen conversation is completely different when you still have cycles, variable ovarian function, and potentially need contraception

• The levonorgestrel IUD, norethindrone acetate 5mg vs. the minipill, and Slynd (drospirenone 4mg) — what each one does and who it’s for

• Exactly how to advocate for yourself at your next appointment

Resources mentioned:

• ESTHER Study (Fournier et al.) — progesterone vs. MPA and breast cancer risk

• Women's Health Initiative (2002)

• Prometrium prescribing information

• Labia Logic (@labialogic) — vulvovaginal specialists | Memorial Day vulvar health post: instagram.com/p/DYqK9uvj2M8

• Sky Women’s Health Podcast — Episode 158: Progesterone Intolerance | podcasts.apple.com/gb/podcast/episode-158-progesterone-intolerance/id1541657642?i=1000640152675

Work with Dr. Moyers: skywomenshealth.com | In-person: Fort Worth, TX | Virtual: Texas & West Virginia

🔗 Connect with Dr. Carolyn Moyers

📸 Instagram: @drcarolynmoyers

🎥 YouTube: @drcarolynmoyers

🌐 Website: www.skywomenshealth.com

Sky Women's Health Podcast is for educational purposes only and does not constitute medical advice. Please consult your own provider for personalized care.